Page last updated: 2024-12-08

5-formyluracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-formyluracil: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-formyluracil : A pyrimidone resulting from the formal oxidation of the alcoholic hydroxy group of 5-hydroxymethyluracil to the corresponding aldehyde. It is a major one-electron photooxidation product of thymine in oligodeoxynucleotides. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID304590
CHEBI ID80961
SCHEMBL ID48228
SCHEMBL ID14940691
MeSH IDM0051156

Synonyms (49)

Synonym
AKOS005565816
AKOS015837503
2,3h)-pyrimidinedione, 5-formyl-
5-formyluracil
1195-08-0
nsc-197200
nsc197200
nsc241524
nsc-241524
2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
5-pyrimidinecarboxaldehyde, 1,2,3,4-tetrahydro-2,4-dioxo-
inchi=1/c5h4n2o3/c8-2-3-1-6-5(10)7-4(3)9/h1-2h,(h2,6,7,9,10
5-pyrimidinecarboxaldehyde,2,3,4-tetrahydro-2,4-dioxo-
5-formyluracil, 98%
STK993842
2,4-dioxo-1h-pyrimidine-5-carbaldehyde
uracil 5-carbaldehyde
C17206
2,4-dihydroxypyrimidine-5-carbaldehyde
STK633477
A18120
2,4-diketo-1h-pyrimidine-5-carbaldehyde
FT-0602403
AM20080141
uracil-5-carboxaldehyde
2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxaldehyde
SCHEMBL48228
2,4-dioxo-5(1h,3h)-pyrimidinecarbaldehyde
2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinecarbaldehyde
CHEBI:80961
mfcd00192185
SCHEMBL14940691
W-200928
2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinecarbaldehyde #
fyu ,
EN300-67513
DTXSID40922994
5-pyrimidinecarboxaldehyde, 1,2,3,6-tetrahydro-2,6-dioxo-
AS-31025
Q21099641
CS-W014360
5-formyl uracil
SB57289
1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinecarboxaldehyde
immureg
SY004533
2,4-dioxo-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde
Z1080487072
PD192639

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" There are no toxic effects of 5-fodUrd on cells defective in thymidine kinase or thymidylate synthetase, suggesting that the toxicity may be caused by 5-fodUrd phosphorylation and subsequent inhibition of thymidylate synthetase."( 5-Formyluracil and its nucleoside derivatives confer toxicity and mutagenicity to mammalian cells by interfering with normal RNA and DNA metabolism.
Bjelland, S; Klungland, A; Matsuda, A; Paulsen, R; Rolseth, V; Seeberg, E; Ueno, Y; Wiik, P; Yamada, Y, 2001
)
1.75
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
pyrimidoneA pyrimidine carrying one or more oxo substituents.
aldehydeA compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group.
nucleobase analogueA molecule that can substitute for a normal nucleobase in nucleic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (4.62)18.7374
1990's12 (18.46)18.2507
2000's31 (47.69)29.6817
2010's14 (21.54)24.3611
2020's5 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.50 (24.57)
Research Supply Index4.20 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]